Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 8;29(3):1796-1807.
doi: 10.3390/curroncol29030147.

Systemic Therapy and Its Surgical Implications in Patients with Resectable Liver Colorectal Cancer Metastases. A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference

Shahid Ahmed  1 , Nicholas Bosma  2 , Michael Moser  3 , Shahida Ahmed  4 , Bryan Brunet  1   5 , Janine Davies  2 , Corinne Doll  6 , Dorie-Anna Dueck  1   7 , Christina A Kim  4 , Shuying Ji  8 , Duc Le  1   5 , Richard Lee-Ying  6 , Howard Lim  2 , John Paul McGhie  9 , Karen Mulder  10 , Jason Park  11 , Deepti Ravi  12 , Daniel J Renouf  2 , Devin Schellenberg  13 , Ralph P W Wong  4 , Adnan Zaidi  1   7
Affiliations

Systemic Therapy and Its Surgical Implications in Patients with Resectable Liver Colorectal Cancer Metastases. A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference

Shahid Ahmed et al. Curr Oncol. .

Abstract

The Western Canadian Gastrointestinal Cancer Consensus Conference (WCGCCC) convened virtually on 4 November 2021. The WCGCCC is an interactive multi-disciplinary conference attended by health care professionals, including surgical, medical, and radiation oncologists; pathologists; radiologists; and allied health care professionals from across four Western Canadian provinces, British Columbia, Alberta, Saskatchewan, and Manitoba, who are involved in the care of patients with gastrointestinal cancer. They participated in presentation and discussion sessions for the purpose of developing recommendations on the role of systemic therapy and its optimal sequence in patients with resectable metastatic colorectal cancer.

Keywords: CRLM; adjuvant therapy; chemotherapy; colorectal liver metastases; consensus; metastasectomy; surgery; systemic therapy.

PubMed Disclaimer

Conflict of interest statement

Author Shahid Ahmed has served on advisory boards for Merck, BMS, Pfizer, Taiho and Roche. Author Karen Mulder has an advisory role for Pfizer Canada, Eisai Inc., Bayer Canada and has received clinical trial funding from Deciphera Pharmaceuticals, BluePrint Medicines, and AstraZeneca. Author Janine Davies has clinical trials for BMS, Merck, MedImmune, Astellas Array BioPharma, and is a consultant and a member of the advisory board for AstraZeneca, Eisai, Taiho, and Amgen. Author Christina A. Kim received an unrelated research grant from Celgene Inc. and an honorarium from Amgen. Author Howard Lim received honoraria from Merck, BMS, AstraZeneca, Eisai, Taiho, Roche, Amgen, and Bayer for consultant work. Author Richard Lee-Ying had advisory roles for Eisai, Ipsen, AstraZeneca, Roche, and Celgene. Author Daniel J. Renouf received unrelated research funding and honoraria from Bayer and Roche, and travel funding and honoraria from Servier, Celgene, Taiho, Ipsen, and AstraZeneca. Author Adnan Zaidi has provided consultant work for Merck and BMS. The remaining authors declare no conflict of interest.

References

    1. Wiederkehr J., Wiederkehr B., Wiederkehr H. Surgical Challenges in the Management of Liver Disease. BoD–Books on Demand; Norderstedt, Germany: 2019. Colorectal liver metastases. - DOI
    1. Abdalla E.K., Vauthey J.-N., Ellis L.M., Ellis V., Pollock R., Broglio K.R., Hess K., Curley S.A. Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases. Ann. Surg. 2004;239:818–827. doi: 10.1097/01.sla.0000128305.90650.71. - DOI - PMC - PubMed
    1. Fong Y., Fortner J., Sun R.L., Brennan M.F., Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann. Surg. 1999;230:309–318. doi: 10.1097/00000658-199909000-00004. - DOI - PMC - PubMed
    1. Morris E.J.A., Forman D., Thomas J.D., Quirke P., Taylor E.F., Fairley L., Cottier B., Poston G. Surgical management and outcomes of colorectal cancer liver metastases. Br. J. Surg. 2010;97:1110–1118. doi: 10.1002/bjs.7032. - DOI - PubMed
    1. de Jong M.C., Pulitano C., Ribero D., Strub J., Mentha G., Schulick R.D., Choti M.A., Aldrighetti L., Capussotti L., Pawlik T.M. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: An international multi-institutional analysis of 1669 patients. Ann. Surg. 2009;250:440–448. doi: 10.1097/SLA.0b013e3181b4539b. - DOI - PubMed

Publication types